Ainos Inc (AIMD)

Name: Ainos Inc (AIMD) Share Price Today, Stock Analysis, Annual Report | Value Research
Brand: Ainos Inc (AIMD)

Stock Card

$1.41

$-0.01 (-0.70%)

As on 28-Aug-2026 16:00EDT

Market cap

$11 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

P/B Ratio

3.2

Div. Yield

0 %

Ainos Inc (AIMD) Share Price

Compare

High: Low: Return:

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 1.39 High: 1.44

52 Week Range

Low: 1.26 High: 4.44

Liquidity

Low Moderate High

Fundamentals

Net Profit (TTM)

$0 Mln
ROE

-2 %
ROCE

-- %
Industry P/E

--
EV/EBITDA

-1.6
Debt to Equity

0
Book Value

$--
EPS

$-2.3
Face value

--
Shares outstanding

7,384,073

10 Years Aggregate

CFO

$-13.37 Mln

EBITDA

$-25.87 Mln

Net Profit

$-38.53 Mln

Company	YTD	1 Month	3 Months	1 Year	3 Years	5 Years	10 Years
Ainos Inc (AIMD)	-14.0	6.0	-44.9	-62.9	-54.9	-67.0	18.3
BSE Sensex	-8.8	0.6	1.8	-4.4	6.0	6.6	10.8
S&P Small-Cap 600^#	-5.8	-5.3	-13.7	-6.3	5.3	3.0	5.5

As on 28-Aug-2026 | #As on 26-Oct-2023

Company	2025	2024	2023
Ainos Inc (AIMD)	-28.1	-77.5	-33.9
S&P Small-Cap 600	4.0	7.0	13.9
BSE Sensex	9.1	8.1	18.7

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details

Key Ratios

View Details

Peers

View Details

Company	Price ($)	Market Cap ($ Mln)	Revenue (TTM)	Net Profit (TTM)	OPM (%)	ROE (%)	P/E	P/B
Ainos Inc (AIMD)	1.4	10.6	0.0	-14.5	-100,939.0	-266.5	--	3.2
Arrowhead Pharmaceuticals (ARWR)	84.9	12,304.7	669.5	-320.0	-0.8	-71.1	--	26.4
Ascendis Pharma A/S - ADR	246.7	16,614.0	1,054.4	755.9	5.7	--	19.4	10.1
Cytokinetics Inc (CYTK)	72.3	10,682.6	71.0	-894.0	-1,175.8	--	--	60.3
Exelixis (EXEL)	54.2	13,400.0	2,435.9	860.6	31.0	43	17	7.3
Halozyme Therapeutics (HALO)	105.3	12,277.1	1,663.7	413.6	36.3	430	31.2	83.9
Krystal Biotech (KRYS)	350.5	10,258.4	440.5	241.5	33.4	18.7	42.2	7.3
Madrigal Pharmaceuticals (MDGL)	534.5	11,938.8	1,283.9	-325.1	-19.0	-57.7	--	22.9
Medpace Holdings (MEDP)	603.9	17,326.2	2,782.3	491.5	21.1	110.1	36.5	39.4
Praxis Precision MedicinesÂ Inc (PRAX)	348.4	10,496.2	0.0	-339.1	--	-30.6	--	7.6

Shareholding Pattern

View Details

About Ainos Inc (AIMD)

Ainos, Inc., a dual-platform company, focusing artificial intelligence"based smelltech technologies and immune therapeutics. It offers AI Nose, an AI-based electronic olfaction system, which uses a smell language model to digitize scent into Smell... IDs and turning into machine-readable data. The company provides its platforms for semiconductor manufacturing, robotics, and smart manufacturing industries; as well as senior care and women's health sectors. In addition, it develops VELDONA, a low-dose oral interferon platform for human and animal health applications, targeting rare, autoimmune, and infectious diseases. The company was formerly known as Amarillo Biosciences, Inc. and changed its name to Ainos, Inc. in May 2021. Ainos, Inc. was incorporated in 1984 and is based in Houston, Texas. Ainos, Inc. is a subsidiary of Taiwan Carbon Nano Technology Corporation. Read more

Chairman of Board, President & CEO

Mr. Chun-Hsien Tsai
Chairman of Board, President & CEO

Mr. Chun-Hsien Tsai
Headquarters

Houston, TX
Website

https://www.ainos.com

FAQs for Ainos Inc (AIMD)

What is the current share price of Ainos Inc (AIMD) Today?

The share price of Ainos Inc (AIMD) is $1.41 (NASDAQ) as of 28-Aug-2026 16:00 EDT. Ainos Inc (AIMD) has given a return of -54.9% in the last 3 years.

What is the current PB & PE ratio of Ainos Inc (AIMD)?

Since, TTM earnings of Ainos Inc (AIMD) is negative, P/E ratio is not available.
The P/B ratio of Ainos Inc (AIMD) is 3.22 times as on 21-Aug-2026, a 40 discount to its peers’ median range of 5.35 times.

PE & PB ratio at the end of financial year.